InvestorsHub Logo
Followers 230
Posts 21508
Boards Moderated 2
Alias Born 08/03/2006

Re: trueblue post# 14156

Monday, 08/01/2016 8:27:49 AM

Monday, August 01, 2016 8:27:49 AM

Post# of 15766
Mast Therapeutics Announces Initiation Of Phase 2 Study Of AIR001 Conducted By The Heart Failure Clinical Research Network

August 01, 2016

https://finance.yahoo.com/news/mast-therapeutics-announces-initiation-phase-120000416.html


==================

Most of us have been watching the level II's. Plenty of share swapping and resistance has been a real pain. Watching something that's stuck in a sideways trend is a deterrent. Currently waiting on data and now officially launching the heart failure P2 may bring in enough powder to cut through resistance. Of course shorts are banking that the EPIC trial won't have enough tangible evidence to move forward. Double blind trials are completely blinded until results are published, so any rumors one way or another are just that. Then comes the habitual funding and thoughts that another raise is just around the corner. I expect them to wait for the EPIC trial data. Company says mid Sept, though I'm thinking much sooner, like within the next couple weeks. Just my own guess. Good data will certainly be a boost.

"Perfection is not attainable, but if we chase perfection we can catch
excellence." Vince Lombardi
Do your research! Play the TA. All posts are my opinion.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MSTX News